Shares of pharma exporters such as Aurobindo Pharma, Dr Reddy’s Laboratories, Lupin, Sun Pharma and Zydus Lifesciences are in focus on Friday morning after the US President Donald Trump in a social media post said a 100 per cent tariff will be imposed on any braded or patented pharma product, unless a company is building its pharma manufacturing plant in the US. This, the US President said, will include under construction and/or breaking ground. Advertisement

"There will be no tariff on these pharmaceutical products if construction has started," he said.

Pharmaceuticals were earlier exempted under Section 232 investigations. Aurobindo Pharma exports account for 89 per cent of its sales. Out of these exports, exports to the US stood at 49 per cent. Similarly, US exports as percentage of

See Full Page